Okay, let's tackle this question. The user is asking about a long-acting beta-2 selective agonist. First, I need to recall what beta-2 agonists are. They're used in respiratory conditions like asthma and COPD. Beta-2 agonists work by stimulating beta-2 adrenergic receptors in the lungs, causing bronchodilation.

Now, the key here is distinguishing between short-acting and long-acting beta-2 agonists. Short-acting ones, like albuterol (salbutamol), have a quick onset and short duration, used for acute symptoms. Long-acting ones, such as salmeterol, formoterol, or vilanterol, have a longer duration, used for maintenance therapy.

The question asks for a long-acting beta-2 selective agonist. So the correct answer should be one of the long-acting ones. Let's think about the options. Common LAMAs (long-acting muscarinic antagonists) are tiotropium, which are anticholinergics, not beta agonists. So if any of the options include tiotropium, that's incorrect.

Other beta-2 agonists: Salmeterol is a long-acting one, formoterol is also long-acting. If the options include these, they are correct. But if the question lists options like A. Albuterol (short-acting), B. Salmeterol (correct), C. Tiotropium (LAMA), D. Terbutaline (short-acting), then the answer is B.

Wait, the user hasn't provided the options, but the correct answer is supposed to be filled in. Since the user's correct answer is missing, I need to infer based on standard knowledge. The standard long-acting beta-2 agonists are salmeterol, formoterol, vilanterol. So if the correct answer is one of these, that's the right choice.

Now, the explanation should cover the core concept of beta-2 agonists, their classification, and the mechanisms. Then explain why the correct answer is right, and why the others are wrong. For example, if an option is a muscarinic antagonist, that's incorrect. Also, short-acting ones are not the answer here.

Clinical pearl would be to remember that LABAs are used for maintenance in asthma/COPD, not for acute relief. Also, combining with inhaled corticosteroids is common. So the high-yield fact is the difference between SABA and LABA, and their uses.

**Core Concept**
Long-acting beta-2 selective agonists (LABAs) are bronchodilators that stimulate beta-2 adrenergic receptors in airway smooth muscle, providing sustained relaxation. They are used in chronic asthma and COPD management, distinct from short-acting beta-2 agonists (SABAs) like albuterol, which act rapidly but briefly.

**Why the Correct Answer is Right**
The correct answer, **salmeterol**, is a LABA with a duration of 12 hours. It binds irreversibly to beta-2 receptors via a cysteine residue, prolonging its effect. This mechanism differentiates it from short-acting agents like albuterol, which have reversible, reversible interactions. Salmeterol

✓ Correct Answer: A. Formoterol